DXCM Stock Analysis: Buy, Sell, or Hold?
DXCM - DexCom, Inc.
$75.37
0.12 (0.16%)
▲
5d:
+3.44%
30d:
+28.68%
90d:
+17.33%
BUY
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Smart Money Distribution
None View Scanner →
Strength: 8.0/10
Get Alerted When DXCM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: DXCM shows positive signals but monitor for confirmation. Market pricing in 0.3% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: DXCM shows positive signals but monitor for confirmation. Market pricing in 0.3% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$127.73
Based on 11.4% avg growth
INTRINSIC VALUE TODAY
$79.31
5.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 24.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DXCM is currently trading at $75.37, which is considered extended relative to its 30-day fair value range of $61.79 to $74.93. The stock's valuation (Forward PE: 24.5) is in line with its historical norms (24.3). At these levels, the market is pricing in 0.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DXCM is in a downtrend. Immediate support is located at $71.53, while resistance sits at $78.91.
Market Sentiment: DXCM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $83.83 (+11.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, DXCM is in a downtrend. Immediate support is located at $71.53, while resistance sits at $78.91.
Market Sentiment: DXCM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $83.83 (+11.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$61.79 -
$74.93
Company Quality Score
68/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($83.83)
- NEUTRAL: Market pricing in 0.3% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$61.79 -
$74.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$71.53
Resistance Level
$78.91
Current Trend
Downtrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.46
Wall Street Target
$83.83
(+11.2%)
Revenue Growth (YoY)
15.0%
Earnings Growth (YoY)
92.2%
Profit Margin
19.3%
Valuation Premium vs History
+0.3% premium
PE vs Historical
24.5 vs 24.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.3%
(market-implied from PE analysis)
1-Year Target
$75.60
(+0%)
2-Year Target
$75.82
(+1%)
3-Year Target
$76.05
(+1%)
3-Yr Target (if PE normalizes)
(PE: 24→24)
PE COMPRESSION
$75.54
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.5, Growth: 18.8%)
$126.31
(+68%)
Base:
(SPY PE: 21.9, Growth: 18.8%)
$113.17
(+50%)
Bear:
(PE: 18.6, Growth: 18.8%)
$96.20
(+28%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (32x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 32.30 | Current EPS (TTM): $2.33
Bull Case
$109.45
(+45%)
Analyst growth 32.2%, PE expands to 35.5
Base Case
$99.50
(+32%)
Market implied 32.2%, PE stable at 32.3
Bear Case
$51.17
(-32%)
Severe decline -20.0%, PE contracts to 27.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 13, 2026 7:56 AM ET
Data refreshes hourly during market hours. Next update: 8:56 AM
Data refreshes hourly during market hours. Next update: 8:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DXCM showing a specific setup today?
Insider Activity (6 Months)
3
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Jon Brown
SELL
1700 shares
2026-04-15
Ro Khanna
SELL
2026-03-30
Ro Khanna
SELL
2026-03-23
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$78 | 60 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$117 | 62 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$99 | 61 BUY |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$99 | 60 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 48 HOLD |
Advanced DXCM Option Strategies
Professional options setups generated by AI based on today's DXCM price and gamma walls.
